Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Expression of osteoprotegrin is enhanced in lung cancer tissues and promotes aggressive cellular traits in H3122 lung cancer cells

Yu, Zhen, Sanders, Andrew J. ORCID: https://orcid.org/0000-0002-7997-5286, Owen, Sioned, Cheng, Shan, Yang, Xiaomei and Jiang, Wen G. ORCID: https://orcid.org/0000-0002-3283-1111 2017. Expression of osteoprotegrin is enhanced in lung cancer tissues and promotes aggressive cellular traits in H3122 lung cancer cells. Anticancer Research 37 (8) , pp. 4277-4283. 10.21873/anticanres.11820

[thumbnail of Yu et al OPG AR 2017 reprint.pdf]
Preview
PDF - Published Version
Download (2MB) | Preview

Abstract

Background: Osteoprotegrin (OPG), a secreted protein and a member of the tumor necrosis factor receptor superfamily has been well-characterized and is an important regulator of bone remodeling by blocking osteoclast maturation thus preventing osteolysis. In recent years, OPG has been reported to have an association with the malignant capacity of various cancer types and cancer-associated bone metastasis, although the mechanisms of this are not clearly understood. Materials and Methods: In this study, OPG expression was analyzed in human lung cancer tissue and normal tissue based on the dataset of The Cancer Genome Atlas and Oncomine. The in vitro effect of OPG on H3122 lung cancer cells was also assessed by characterizing cell function following knock-down and forced overexpression in this cell line. Results: The expression of OPG was significantly increased in lung cancer tissues compared to the normal control group and OPG promoted the malignant phenotypes of H3122 cells in in vitro models. Conclusion: OPG may be a potential driver of lung cancer cells and therefore might have potential in therapy and diagnostics.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Publisher: International Institute of Anticancer Research (IIAR)
ISSN: 0250-7005
Funders: Cancer Research Wales and Cardiff University China Medical Scholarship
Date of First Compliant Deposit: 15 January 2018
Date of Acceptance: 25 April 2017
Last Modified: 20 Sep 2023 21:35
URI: https://orca.cardiff.ac.uk/id/eprint/103035

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics